42 (PB030): A novel small-molecule CBP/p300 HAT domain inhibitor demonstrates potent in vivo activity and a favorable safety profile in preclinical species
Titel:
42 (PB030): A novel small-molecule CBP/p300 HAT domain inhibitor demonstrates potent in vivo activity and a favorable safety profile in preclinical species
Auteur:
Hearn, K. Ahn, M. Bevan, L. Chessari, G. Clark, M. Cons, B. Espana-agusti, J. Ferro, K. Howard, A. Lyons, J. Martins, V. Morgillo, C. Palmer, N. Rapti, M. Shah, A. Smyth, T. Unbekandt, M. Varshney, D. Hamlett, C.